0.1040SEK-6.31%Mkt Cap: 68.97M SEKP/E: —Last update: 2026-06-01
Spago Nanomedical AB (publ), a clinical phase nanomedicine company, engages in the development of nanomedicines for cancer diagnostics and treatment primarily in Sweden. Its products include SpagoPix (SN132D), an MRI con…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap68.97M SEK
Enterprise Value50.05M SEK
Revenue (TTM)4.82M SEK
Gross Profit-11.04M SEK
Net Income (TTM)-26.55M SEK
Revenue/Share0.0130 SEK
Last Price0.1040 SEK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees5
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.59
PEG—
EV/EBITDA-1.87
EV/Revenue10.38
P/S15.27
P/B2.41
EPS (TTM)-0.06
EPS (Forward)—
52W Range
0.08425% of range0.4600
52W High0.4600 SEK
52W Low0.0842 SEK
Profitability
Gross Margin-2527.23%
Oper. Margin-733.49%
EBITDA Margin0.00%
Profit Margin-6076.43%
ROE-86.37%
ROA-72.39%
Growth
Revenue Growth-55.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-28.30M SEK
CapEx (TTM)229.00K SEK
FCF Margin-363.29%
FCF Yield-25.40%
Net Debt-29.67M SEK
Net Debt/EBITDA1.11
Balance Sheet
Debt/Equity—
Current Ratio6.96
Quick Ratio5.77
Book Value/Sh0.0460 SEK
Cash/Share0.0450 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating0.0 (Hold)
Target (Mean)0.2650 SEK
Target Range0.2650 SEK – 0.2650 SEK
# Analysts1
Ownership
Shares Out.663.19M
Float424.27M
Insiders38.74%
Institutions1.80%
Technical
SMA 500.1176 (-11.6%)
SMA 2000.1462 (-28.9%)
Beta1.30
S&P 52W Chg27.70%
Avg Vol (30d)566.68K
Avg Vol (10d)610.98K
Technical Indicators
RSI (14)41.8
MACD-0.0010
MACD Signal0.0019
MACD Hist.-0.0030
BB Upper0.1450 SEK
BB Middle0.1251 SEK
BB Lower0.1052 SEK
BB Width31.88%
ATR (14)0.0133 SEK
Vol Ratio (20d)0.46x